Fingerprint
Dive into the research topics of 'Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma
Danai D. Daliani, Vasily Assikis, Shi Ming Tu, Christos N. Papandreou, Lance C. Pagliaro, Tammy Holtkamp, Xumei Wang, Peter F. Thall, Christopher J. Logothetis
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations